Hong Qian
About me
Hong Qian, Ph.D, docent, Associate prof., is a group leader for the research group
Leukemia niche [1] at the Center for Hematology and Regenerative Medicine
(HERM) at Karolinska Institutet.
Hong Qian was recruited to HERM as an assistant professor in 2012. She
received her Ph.D. degree in Stem Cell Biology from Lund University, Sweden
(2007) and did a postdoc at the Department of Clinical and Experimental
Medicine, Linköping University, Sweden (2008-2011).
2004-2007. Ph.D. study in Stem Cell Biology from Lund University, Sweden.
2008-2011, a postdoc at the Department of Clinical and Experimental Medicine,
Linköping University, Sweden (2008-2011).
[1] https://ki.se/en/medh/hong-qian-group-leukemia-niche
Research
Our research program mainly focuses on the role of the hematopoietic niche
in bone marrow in myeloid leukemia using both mouse models and patient
materials. Several advanced techniques including multi-color flow cytometry,
confocal imaging, RNA sequencing and experimental transplantation are
required for the projects.
We are aiming to decipher in vivo activities of mesenchymal cell niche in
bone marrow during normal hematopoiesis and hematological disorders including
leukemia.
The potential findings from this research program may help to understand
cellular mechanisms underlying the regulation of hematopoiesis and to
develop better therapeutic strategies targeting the bone marrow niche for
patients with chronic myeloid leukemia or acute myeloid leukemia.
Teaching
Teaching master and doctoral students or above on Cancer stem cells, Frontier in Biomedicine, Flow Cytometry and Basic Hematology.
Articles
- Article: NATURE COMMUNICATIONS. 2024;15(1):7966
- Article: SCIENTIFIC REPORTS. 2023;13(1):21787
- Journal article: BLOOD. 2023;142:1786
- Journal article: BLOOD. 2023;142:2707
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2023;133(20):e169671
- Article: JOURNAL OF EXPERIMENTAL MEDICINE (JEM). 2023;220(10):e20220953
- Article: CELL REPORTS. 2023;42(8):112961
- Article: BLOOD. 2023;142(1):73-89
- Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2023;152(1):205-213
- Article: CANCER COMMUNICATIONS. 2023;43(6):637-660
- Article: BLOOD. 2022;139(20):3040-3057
- Article: FRONTIERS IN IMMUNOLOGY. 2022;13:880668
- Article: EMBO MOLECULAR MEDICINE. 2020;12(3):e10419
- Article: NATURE. 2019;567(7747):234-238
- Article: SCIENTIFIC REPORTS. 2018;8(1):11202
- Article: HAEMATOLOGICA. 2018;103(7):1169-1181
- Article: BLOOD ADVANCES. 2018;2(12):1480-1494
- Article: BLOOD ADVANCES. 2018;2(5):534-548
- Article: STEM CELLS TRANSLATIONAL MEDICINE. 2017;6(10):1840-1851
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2017;490(2):378-384
- Article: LEUKEMIA AND LYMPHOMA. 2017;58(8):1903-1913
- Article: STEM CELLS. 2017;35(7):1799-1814
- Article: NATURE MEDICINE. 2017;23(6):692-702
- Article: BLOOD. 2017;129(16):2266-2279
- Article: ELIFE. 2017;6:e25902
- Article: THE FASEB JOURNAL. 2017;31(3):1067-1084
- Article: STEM CELLS TRANSLATIONAL MEDICINE. 2016;5(11):1485-1495
- Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2015;48:31-41
- Article: ADVANCED FUNCTIONAL MATERIALS. 2015;25(25):3907-3915
- Article: STEM CELLS AND DEVELOPMENT. 2015;24(12):1405-1414
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2013;288(46):33449-33461
- Article: MOLECULAR AND CELLULAR BIOLOGY. 2013;33(4):661-677
- Article: STEM CELLS. 2013;31(2):360-371
- Article: ENDOCRINOLOGY. 2012;153(10):4849-4861
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(39):15871-15876
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2012;287(31):25795-25807
- Article: BLOOD. 2011;118(5):1283-1290
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2010;285(47):36275-36284
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2009;390(3):883-886
- Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2009;383(3):336-339
- Article: JOURNAL OF IMMUNOLOGY. 2008;180(4):2045-2053
- Article: CELL STEM CELL. 2007;1(6):671-684
- Article: BLOOD. 2007;110(7):2399-2407
- Article: IMMUNITY. 2007;26(4):407-419
- Article: GENES & DEVELOPMENT. 2006;20(15):2018-2023
- Article: BLOOD. 2006;107(9):3503-3510
- Article: ZHONGGUO YING YONG SHENG LI XUE ZA ZHI = ZHONGGUO YINGYONG SHENGLIXUE ZAZHI = CHINESE JOURNAL OF APPLIED PHYSIOLOGY. 2004;20(3):254-258
- Article: ZHONGGUO YING YONG SHENG LI XUE ZA ZHI = ZHONGGUO YINGYONG SHENGLIXUE ZAZHI = CHINESE JOURNAL OF APPLIED PHYSIOLOGY. 2001;17(4):326-395
- Article: ACTA PHARMACOLOGICA SINICA. 2001;22(4):349-354
- Show more
All other publications
- Preprint: BIORXIV. 2022
- Letter: HAEMATOLOGICA. 2020;105(3):e102-e106
- Editorial comment: STEM CELLS INTERNATIONAL. 2018;2018:4879379-3
- Meeting abstract: BLOOD. 2016;128(22):27
- Meeting abstract: BLOOD. 2016;128(22):1488
- Letter: LEUKEMIA. 2016;30(6):1399-1402
- Book chapter: TISSUE ENGINEERING. 2014;p. 427-469
Grants
- Swedish Research Council1 January 2023 - 31 December 2025
- Swedish Research Council1 January 2023 - 31 December 2026
- Swedish Research Council1 January 2020 - 31 December 2022
- Knut and Alice Wallenberg Foundation1 January 2020 - 1 January 2025
- The search for new therapeutic strategies targeting the bone marrow environment for the treatment of myeloid leukemiaSwedish Cancer Society1 January 2018
- The search for new therapeutic strategies targeting the bone marrow environment for the treatment of myeloid leukemiaSwedish Cancer Society1 January 2017
- What role do the mesenchymal stem cells play in the bone marrow in blood cancer - a way to develop new treatment strategiesSwedish Cancer Society1 January 2016
- What role do the mesenchymal stem cells play in the bone marrow in blood cancer - a way to develop new treatment strategiesSwedish Cancer Society1 January 2015
- The importance of stromal bone marrow stem cells for blood cancer and normal blood formationSwedish Cancer Society1 January 2014
- Swedish Research Council1 January 2013 - 31 December 2015
Employments
- Principal Researcher, Department of Medicine, Huddinge, Karolinska Institutet, 2022-
Degrees and Education
- Docent, Karolinska Institutet, 2022